ArticleCancer science2012

Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography.

Arifudin Achmad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.